Taking the Path Less Traveled: How Responsible Leadership Addresses a Grand Challenge in Public Health, a Case Study from China

This study unpacks how responsible leadership driven by a social mission can accomplish both social objectives and financial goals to support an organization's survival. We focus on a social enterprise in the healthcare industry in China and examine how it balances its social mission and econom...

Full description

Saved in:
Bibliographic Details
Published in:Management and organization review 2023-08, Vol.19 (4), p.838-855
Main Authors: Zhang, Zhi-Xue, Yi, Xiwei, Dong, Yuntao
Format: Article
Language:English
Subjects:
Aging
Blood diseases
Business models
Case studies
Chronic illnesses
Diagnostic tests
Economic reform
Entrepreneurs
Health care industry
Health care policy
Hospitals
Infectious diseases
Leadership
Pathology
Public health
Severe acute respiratory syndrome
Social entrepreneurship
Society
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study unpacks how responsible leadership driven by a social mission can accomplish both social objectives and financial goals to support an organization's survival. We focus on a social enterprise in the healthcare industry in China and examine how it balances its social mission and economic goals by enlarging the capacity of medical institutions and providing high-quality services to a high number of patients. Through our analysis of the case firm, we reveal the motivation and actions of an entrepreneur in establishing a socially responsible firm and the social implications of responsible leadership in operating such an enterprise. We provide an important supplement and extension to the work of Smith and Besharov (2019) by demonstrating how a responsible leader in China manages the process of balancing social and economic goals. We further contribute to the understanding of how a socially responsible firm can improve the healthcare industry and the reform of China's healthcare.
ISSN:1740-8776
1740-8784
DOI:10.1017/mor.2022.54